Phase 2 N=101 A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors
Broad Solid Tumor
Primary: Number of Participants With Adverse Events — 1; 2; 3; 4 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=95 Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
Prostate Cancer
Primary: Micro-Ultrasound Detection of High Grade Prostate Cancer (Gleason Score ≥7) vs. Surgical Pathology — 38; 50 participants
Phase 4 N=90 Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis
Knee Osteoarthritis
Primary: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Measurements — 32.1; 35.3; 19.5; 19.8 score on a scale
Phase 2 N=108 Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
Breast Cancer
Primary: Number of Participants With at Least One Treatment-related Adverse Event of Interest — 15; 20 Participants
Phase 3 N=5 Liraglutide in Adolescents With Type 1 Diabetes
Type 1 Diabetes
Primary: Mean Weekly Blood Glucose — 187; 178 mg/dL
N/A N=27 Community Spirit in Residence for the Elderly
Sense of Community
Primary: Sense of Community Factors
N/A N=500 RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Aphakia · Cataract
Primary: Absolute Manifest Refraction Spherical Equivalent (MRSE) Compared Between the Two Study Groups, LAL and Control — 0.210; 0.345 Diopters
N/A N=277 SKIPping With PAX: An Integrated Gross Motor and Social-Emotional Skill Intervention
Gross Motor Development Delay · Social Skills · Social Behavior
Primary: Test of Gross Motor Development, Third Edition — 41.99; 43.36 score on a scale
N/A N=29 Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 Diabetes Patients (T2D)
Diabetes Type 2
Primary: Time in Range (TIR) — 36.61; 63.03 percentage of time — p=<.001
N/A N=73 Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
Diabetic Foot Ulcer
Primary: Wound Closure Within 12 Weeks With the Use of Topical Wound Oxygen Therapy (TWO2) — 15; 5 Participants
Phase 4 N=103 Individualizing Treatment for Asthma in Primary Care
Asthma · Bronchial Diseases · Respiratory Tract Infections
Primary: Asthma Control as Measured by the Asthma Control Test (ACT) — 18.77; 18.96; 20.45; 20.14 units on a scale
N/A N=50 Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes
Smoking Cessation · Harm Reduction · E-Cig Use
Primary: Effects of Devaluation on Switching From Cigarettes to the JUUL E-cigarette — 4; 4 Participants
Phase 2 N=120 Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)
Binge Drinking · HIV
Primary: Binge Drinking Days Per Week — 1.056; 1.722 days per week
N/A N=56 Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure
Heart Failure，Congestive
Primary: Intervention Acceptability — 19; 25 Participants
N/A N=46 Efficacy Evaluation of Two Different Fluoride Applications
White Spot Lesion
Primary: Measurement of White Spot Lesions by QLF Parameters: Delta F (Max) — -28.2; -26.3 percent change (%)